Keun Suk Yang

544 total citations
9 papers, 472 citations indexed

About

Keun Suk Yang is a scholar working on Nephrology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Keun Suk Yang has authored 9 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Keun Suk Yang's work include Renal Transplantation Outcomes and Treatments (2 papers), Parathyroid Disorders and Treatments (2 papers) and Adipose Tissue and Metabolism (2 papers). Keun Suk Yang is often cited by papers focused on Renal Transplantation Outcomes and Treatments (2 papers), Parathyroid Disorders and Treatments (2 papers) and Adipose Tissue and Metabolism (2 papers). Keun Suk Yang collaborates with scholars based in South Korea, United Kingdom and United States. Keun Suk Yang's co-authors include Bum Soon Choi, Yoon Sik Chang, Sungjin Chung, Yu Ah Hong, Seok Joon Shin, J. H. Lee, S.H. Koh, Y. S. Kim, Hyun‐Woo Kim and Cheol Whee Park and has published in prestigious journals such as PLoS ONE, Diabetologia and Transplantation.

In The Last Decade

Keun Suk Yang

9 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keun Suk Yang South Korea 8 181 115 114 103 101 9 472
Jiamei Lu China 13 264 1.5× 68 0.6× 55 0.5× 48 0.5× 88 0.9× 24 542
Mark A. Bryniarski United States 10 188 1.0× 94 0.8× 76 0.7× 59 0.6× 50 0.5× 14 411
Jiarong Xu China 8 157 0.9× 49 0.4× 48 0.4× 66 0.6× 142 1.4× 12 425
Yongli Zhan China 13 185 1.0× 68 0.6× 203 1.8× 31 0.3× 97 1.0× 33 636
You Na China 6 175 1.0× 62 0.5× 50 0.4× 66 0.6× 130 1.3× 8 364
Pengxun Han China 11 202 1.1× 72 0.6× 84 0.7× 23 0.2× 71 0.7× 22 392
Weiyan Lai China 9 139 0.8× 50 0.4× 113 1.0× 64 0.6× 79 0.8× 15 389
Hengjiang Guo China 13 247 1.4× 64 0.6× 196 1.7× 19 0.2× 135 1.3× 14 647
Shumin Cai China 10 186 1.0× 38 0.3× 50 0.4× 65 0.6× 129 1.3× 14 399
Rena Pollack Israel 13 159 0.9× 103 0.9× 39 0.3× 52 0.5× 142 1.4× 32 676

Countries citing papers authored by Keun Suk Yang

Since Specialization
Citations

This map shows the geographic impact of Keun Suk Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keun Suk Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keun Suk Yang more than expected).

Fields of papers citing papers by Keun Suk Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keun Suk Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keun Suk Yang. The network helps show where Keun Suk Yang may publish in the future.

Co-authorship network of co-authors of Keun Suk Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Keun Suk Yang. A scholar is included among the top collaborators of Keun Suk Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keun Suk Yang. Keun Suk Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Yang, Keun Suk, Ji‐il Kim, In Sung Moon, et al.. (2014). Use of Bortezomib as Anti-Humoral Therapy in Kidney Transplantation. Journal of Korean Medical Science. 29(5). 648–648. 17 indexed citations
2.
Hwang, Hyeon Seok, Sun Woo Lim, In O Sun, et al.. (2014). Clinical Significance of Preexisting Microcalcification in the Iliac Artery in Renal Transplant Recipients. Transplantation. 99(4). 811–817. 11 indexed citations
3.
Yang, Keun Suk, Ji Hee Lim, Tae Woo Kim, et al.. (2014). Vascular Endothelial Growth Factor-Receptor 1 Inhibition Aggravates Diabetic Nephropathy through eNOS Signaling Pathway in db/db Mice. PLoS ONE. 9(4). e94540–e94540. 29 indexed citations
4.
Hong, Yu Ah, Ji Hee Lim, Min Young Kim, et al.. (2014). Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice. PLoS ONE. 9(5). e96147–e96147. 101 indexed citations
5.
Hong, Yu Ah, Ji Hee Lim, Min Young Kim, et al.. (2014). Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease. Clinical and Experimental Nephrology. 19(2). 208–215. 14 indexed citations
6.
Yang, Keun Suk, et al.. (2013). The Clinical Outcome of End-Stage Renal Disease Patients Who Return to Peritoneal Dialysis After Renal Allograft Failure. Transplantation Proceedings. 45(8). 2949–2952. 7 indexed citations
7.
Hong, Yu Ah, Keun Suk Yang, Sungjin Chung, et al.. (2012). Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice. Diabetologia. 56(1). 204–217. 276 indexed citations
8.
Yoon, Young Kyung, Hak Jun Kim, Won Jin Lee, et al.. (2012). Clinical prediction rule for identifying patients with vancomycin-resistant enterococci (VRE) at the time of admission to the intensive care unit in a low VRE prevalence setting. Journal of Antimicrobial Chemotherapy. 67(12). 2963–2969. 16 indexed citations
9.
Kim, Ka Young, et al.. (2012). A Case of Adipsic Hypernatremia Associated with Anomalous Corpus Callosum in Adult with Mental Retardation. Endocrinology and Metabolism. 27(3). 232–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026